Detection of point mutations in KRAS oncogene by real-time PCR-based genotyping assay in GIT diseases

被引:2
作者
Ugorcakova, J. [1 ]
Hlavaty, T. [1 ]
Novotna, T. [1 ]
Bukovska, G. [1 ]
机构
[1] Slovak Acad Sci, Inst Mol Biol, SK-84551 Bratislava, Slovakia
来源
BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY | 2012年 / 113卷 / 02期
关键词
colorectal carcinoma; KRAS; codon; 12; mutation; pancreatic carcinoma; real-time PCR; K-RAS MUTATIONS; MUTANT-ENRICHED PCR; ACID CLAMP PCR; COLORECTAL-CANCER; PANCREATIC-CANCER; GENE-MUTATIONS; CARCINOMA; DNA; ALLELES; SAMPLES;
D O I
10.4149/BLL_2012_018
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: The determination of gene mutations is important for the diagnosis and prognosis of various gastrointestinal cancers. The aim of our study was to develop a new procedure for the analysis of KRAS gene mutation by application of the real-time PCR method. Background: The detection process requires discriminate trace amount of mutant allele in a large excess of wild-type DNA in various samples. Methods: The real-time PCR based technique using hybridization probes for five most frequently KRAS codon 12 mutations and WT specific peptide nucleic acid (PNA) was performed. Our multiplex detection system was tested in various DNA samples (tissue, bile, pancreatic juice) of patients with different diagnoses of gastrointestinal tract disease obtained by endoscopy and ERCP. Results: We designed and optimized the real-time PCR conditions and tested various amount of PNA in PCR reaction to suppress amplification of the wild-type DNA. We determined the interassay variability of the melting temperatures and the results of mutation testing were confirmed by DNA sequencing with the 100 % accuracy. Incidence of searched mutations was 67.5 % in cohort of 40 patients; for KRAS(G12D) it was in 44.4 %, KRAS(G12V) in 22.2 %, KRAS(G12S) in 14.8 %, KRAS(G12A) in 14.8 % and KRAS(G12C) in 3.8 %. The sensitivity of the assays is 1x10(-5). Conclusions: Advantages of this technique are rapidity, accuracy and it is generally easy to perform. This method can be adapted for synchronic detection of multiple mutations and after readjustment by other type mutation of KRAS gene may serve as useful clinical tool for analyzing point mutations in various clinical samples (Tab. 3, Fig. 3, Ref. 42). Full Text in PDF www.elis.sk.
引用
收藏
页码:73 / 79
页数:7
相关论文
共 44 条
[1]  
Al-Mulla F, 1999, J PATHOL, V187, P433, DOI 10.1002/(SICI)1096-9896(199903)187:4<433::AID-PATH273>3.0.CO
[2]  
2-E
[3]   American Society of Clinical Oncology Provisional Clinical Opinion: Testing for KRAS Gene Mutations in Patients With Metastatic Colorectal Carcinoma to Predict Response to Anti-Epidermal Growth Factor Receptor Monoclonal Antibody Therapy [J].
Allegra, Carmen J. ;
Jessup, J. Milburn ;
Somerfield, Mark R. ;
Hamilton, Stanley R. ;
Hammond, Elizabeth H. ;
Hayes, Daniel F. ;
McAllister, Pamela K. ;
Morton, Roscoe F. ;
Schilsky, Richard L. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (12) :2091-2096
[4]   Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer [J].
Amado, Rafael G. ;
Wolf, Michael ;
Peeters, Marc ;
Van Cutsem, Eric ;
Siena, Salvatore ;
Freeman, Daniel J. ;
Juan, Todd ;
Sikorski, Robert ;
Suggs, Sid ;
Radinsky, Robert ;
Patterson, Scott D. ;
Chang, David D. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (10) :1626-1634
[5]   FLAG assay as a novel method for real-time signal generation during PCR: application to detection and genotyping of KRAS codon 12 mutations [J].
Amicarelli, Giulia ;
Shehi, Erlet ;
Makrigiorgos, G. Mike ;
Adlerstein, Daniel .
NUCLEIC ACIDS RESEARCH, 2007, 35 (19)
[6]  
[Anonymous], CLIN ADV HEMATOL ONC
[7]   Specific codon 13 K-ras mutations are predictive of clinical outcome in colorectal cancer patients, whereas codon 12 K-ras mutations are associated with mucinous histotype [J].
Bazan, V ;
Migliavacca, M ;
Zanna, I ;
Tubiolo, C ;
Grassi, N ;
Latteri, MA ;
La Farina, M ;
Albanese, I ;
Dardanoni, G ;
Salerno, S ;
Tomasin, RM ;
Labianca, R ;
Gebbia, N ;
Russo, A .
ANNALS OF ONCOLOGY, 2002, 13 (09) :1438-1446
[8]   Detection of K-Ras mutations in tumour samples of patients with non-small cell lung cancer using PNA-mediated PCR clamping [J].
Beau-Faller, M. ;
Legrain, M. ;
Voegeli, A-C ;
Guerin, E. ;
Lavaux, T. ;
Ruppert, A-M ;
Neuville, A. ;
Massard, G. ;
Wihlm, J-M ;
Quoix, E. ;
Oudet, P. ;
Gaub, M. P. .
BRITISH JOURNAL OF CANCER, 2009, 100 (06) :985-992
[9]  
Bernard PS, 2002, CLIN CHEM, V48, P1178
[10]   Mutant KRAS, chromosomal instability and prognosis in colorectal cancer [J].
Castagnola, P ;
Giaretti, W .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2005, 1756 (02) :115-125